SCA Pharma Awards National Outsourced I.V Admixture Services Agreement with Premier Inc
January 09, 2019 at 01:58 pm
Share
SCA Pharma, an FDA approved 503B sterile-compounding organization, announced that they have been awarded a group purchasing agreement for Outsourced I.V. Admixture Services with Premier Inc. Beginning January 1, 2019, this new agreement allowed Premier members, at their discretion, access to a wide range of outsourced pharmaceuticals. SCA features an extensive product catalog containing products in the following pharmaceutical categories: Analgesics, Anesthetics, Antiarrhythmics, Antibiotics, Anticholinergics, Anticoagulants, Antihypertensive Drugs, Diuretics, Electrolytes, Neuromuscular Blockers, Opioid Analgesics, Oxytocic Agents, Reversal Agents, and Vasopressors.
Premier, Inc. is a healthcare improvement company uniting an alliance of approximately 4,350 United States hospitals and health systems and approximately 300,000 other providers and organizations. It operates through two segments: Supply Chain Services and Performance Services. The Supply Chain Services segment includes the Companyâs group purchasing organizations (GPO), supply chain co-management, purchased services, and direct sourcing activities. The Performance Services segment consists of three sub-brands, which include PINC AI, the Companyâs technology and services platform; Contigo Health, the Companyâs direct-to-employer business; and Remitra, the Companyâs digital invoicing and payables business. It delivers technology-enabled platform that offers critical supply chain services, clinical, financial, operational and value-based care software as a service (SaaS) as well as clinical and enterprise analytics licenses, consulting services, and third-party administrator services.